Industry Experts

CMC Director at Sylentis, a leading CDMO specializing in the development and manufacturing of therapeutic oligonucleotides. I bring extensive experience in analytical development, GMP manufacturing, and regulatory strategy for innovative oligonucleotide-based therapies.